Uploaded February 2021 | Updated September 2026, 2 weeks ago
In this UCSF Department of Medicine Covid Grand Rounds, we’ll begin with a discussion of the new vaccine candidates. Just in the past few weeks, we’ve seen new data regarding several vaccines, including J&J, AstraZeneca, and Novavax. Dr. Monica Gandhi will review these new data, and discuss the implications for vaccine supply – and why it’s appropriate to be optimistic about vaccines, even in the face of a sluggish roll-out and the threat of variants. She’ll add a few thoughts about whether vaccinated people can change behavior. Dr. Marguerita Lightfoot then shares insights regarding communicating about vaccines – particularly to communities of color. Finally, Drs. Robert Rodriguez and Eric Goosby describe their experience as members of the Biden Covid-19 Task Force, which guided the early days of the new administration’s response to the pandemic. The session is moderated by UCSF Department of Medicine chair Bob Wachter.
Program
Bob Wachter: Introduction
00:06:14-00:34:50 – The New Vaccines: Monica Gandhi, MD, MPH (Professor of Medicine; Associate Chief of Division of HIV, Infectious Diseases, and Global Medicine at ZSFG; Director of the UCSF-Gladstone Center for AIDS Research; and Medical Director of the HIV Clinic, Ward 86, ZSFG)
00:34:54-00:39:28 – Q&A with Monica Gandhi
00:39:34-00:51:52 – Q&A with Marguerita Lightfoot, PhD (Professor of Medicine; Chief of Division of Prevention Science; Director of the Center for AIDS Prevention Studies and Prevention Research Center)
00:52:02-01:15:27 – President Biden’s Covid-19 Task Force: Eric Goosby, MD (Professor of Medicine; UN Special Envoy on Tuberculosis; Member of President Biden’s Covid-19 Task Force) and Robert Rodriguez, MD (Professor of Emergency Medicine; Member of President Biden’s Covid-19 Task Force)
Bob Wachter: Closing
See previous Covid-19 Medical Grand Rounds:
• January 28: Covid-19: Vaccine Roll-out, the State of the Pandemic, and Variants – in the U.S. and U.K.
youtube.com/watch?v=0M8HjCrrFSI
• January 14: Covid-19: Update on Vaccines and Implications of the New Variants
youtube.com/watch?v=uZranBw5VZM
• December 17: Covid-19: The CDC, Vaccine Roll-Out, and Ethics and Policy Issues Surrounding Immunity Passports
youtube.com/watch?v=UkLmQ5Fe5Qoab
• December 3: Covid-19: How Should We Handle the Schools, and the Challenges of Vaccine Distribution
youtube.com/watch?v=KgceROGONgE
See all UCSF Covid-19 grand rounds, which have been viewed over 1.6 times, here: https://medicine.ucsf.edu/covid-19-news-coverage
In this UCSF Department of Medicine Covid Grand Rounds, we’ll begin with a discussion of the new vaccine candidates. Just in the past few weeks, we’ve seen new data regarding several vaccines, including J&J, AstraZeneca, and Novavax. Dr. Monica Gandhi will review these new data, and discuss the implications for vaccine supply – and why it’s appropriate to be optimistic about vaccines, even in the face of a sluggish roll-out and the threat of variants. She’ll add a few thoughts about whether vaccinated people can change behavior. Dr. Marguerita Lightfoot then shares insights regarding communicating about vaccines – particularly to communities of color. Finally, Drs. Robert Rodriguez and Eric Goosby describe their experience as members of the Biden Covid-19 Task Force, which guided the early days of the new administration’s response to the pandemic. The session is moderated by UCSF Department of Medicine chair Bob Wachter.
Program
Bob Wachter: Introduction
00:06:14-00:34:50 – The New Vaccines: Monica Gandhi, MD, MPH (Professor of Medicine; Associate Chief of Division of HIV, Infectious Diseases, and Global Medicine at ZSFG; Director of the UCSF-Gladstone Center for AIDS Research; and Medical Director of the HIV Clinic, Ward 86, ZSFG)
00:34:54-00:39:28 – Q&A with Monica Gandhi
00:39:34-00:51:52 – Q&A with Marguerita Lightfoot, PhD (Professor of Medicine; Chief of Division of Prevention Science; Director of the Center for AIDS Prevention Studies and Prevention Research Center)
00:52:02-01:15:27 – President Biden’s Covid-19 Task Force: Eric Goosby, MD (Professor of Medicine; UN Special Envoy on Tuberculosis; Member of President Biden’s Covid-19 Task Force) and Robert Rodriguez, MD (Professor of Emergency Medicine; Member of President Biden’s Covid-19 Task Force)
Bob Wachter: Closing
See previous Covid-19 Medical Grand Rounds:
• January 28: Covid-19: Vaccine Roll-out, the State of the Pandemic, and Variants – in the U.S. and U.K.
youtube.com/watch?v=0M8HjCrrFSI
• January 14: Covid-19: Update on Vaccines and Implications of the New Variants
youtube.com/watch?v=uZranBw5VZM
• December 17: Covid-19: The CDC, Vaccine Roll-Out, and Ethics and Policy Issues Surrounding Immunity Passports
youtube.com/watch?v=UkLmQ5Fe5Qoab
• December 3: Covid-19: How Should We Handle the Schools, and the Challenges of Vaccine Distribution
youtube.com/watch?v=KgceROGONgE
See all UCSF Covid-19 grand rounds, which have been viewed over 1.6 times, here: https://medicine.ucsf.edu/covid-19-news-coverage
